News, press releases, commentary and insights from ET Capital.

News

Press Releases

April 2026

ET Capital opens second fund applying index investing approach to early-stage venture

May 2020

ADC Therapeutics SA, the innovative anti-cancer therapeutics business, has floated on the New York Stock Exchange. Demand for the issue was high with an upsized placing and shares trading at an immediate premium.

Press Realease Artical Summary goes here.

August 2026

Carbon Engineering has been acquired by Occidental Petroleum (NYSE: OXY) in a $1.1B all cash transaction.

September 2022

Bango (AIM:BGO) announced the acquisition of Docomo Digital - the global payments business of NTT DOCOMO - bringing an additional $3.5B of end user spend from c.2 billion users worldwide.

April 2021

Phico Therapeutics awarded up to $18.2 million (c.£13.2 million) CARB-X funding to advance SASPject antibacterial therapy through Phase 1 clinical trials.

August 2021

FDA approves first ADC Therapeutics anti-cancer drug, ZYNLONTA™, for clinical use in patients with relapsed or refractory diffuse large B-Cell Lymphoma.

March 2021

ET Capital, in collaboration with Carbon13 - the venture builder for the climate emergency, has launched the first of a series of SEIS funds investing in new businesses focused on signficant carbon emission reduction.

January 2020

ADC Therapuetics announces positive results from pivotal Phase 2 clinical trial of its lead therapeutic.

August 2018

Phico Therapeutics awarded Innovate UK funding for £1.4 million ($1.87M) antibacterial therapy project.

February 2018

ET Capital is appointed manager of UK China Enterprise a fund exploiting the potential of UK innovation and technology driven business to scale-up in China.

October 2017

ADC Therapeutics raises $200 Million in private placing to fund registrational trials of its lead anti-cancer drugs.

November 2016

Phico Therapeutics raises £3.5M in its fight against antibiotic resistant superbugs.

Media

Insight & community

March 2026

Insight Heading

Insight Artical Summary goes here.

Events & Webinars

27

April, 2026

Introduction to Cambridge Venture Index SEIS/EIS Fund 2 (CVIF2)

Join one of our upcoming investor webinars to explore how our index-style, diversified approach is designed to deliver long-term, balanced growth

12

September, 2026

Introduction to Cambridge Venture Index SEIS/EIS Fund 2 (CVIF2)

Join one of our upcoming investor webinars to explore how our index-style, diversified approach is designed to deliver long-term, balanced growth